ONCOLYTIC VACCINIA VIRUS COMBINATION CANCER THERAPY

• 收藏
• 分享

专利权人:

SillaJen Biotherapeutics, Inc.

发明人:

KIRN, David,BREITBACH, Caroline

申请号：

EP20180166620

公开号：

EP3409119(A1)

申请日:

2010.09.14

申请国别(地区):

欧洲专利局

年份:

2018

代理人:

摘要：

Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include evaluating a tumor for reperfusion after treatment with vaccinia virus and administering an anti-angiogenic agent if reperfusion is detected.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/